BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8394069)

  • 1. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.
    Heine HG; Boyle DB
    Arch Virol; 1993; 131(3-4):277-92. PubMed ID: 8394069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
    Heine HG; Hyatt AD; Boyle DB
    Virus Res; 1994 Jun; 32(3):313-28. PubMed ID: 8079513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.
    Bayliss CD; Peters RW; Cook JK; Reece RL; Howes K; Binns MM; Boursnell ME
    Arch Virol; 1991; 120(3-4):193-205. PubMed ID: 1659797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dose and route of inoculation on responses of chickens to recombinant fowlpox virus vaccines.
    Boyle DB; Heine HG
    Vet Microbiol; 1994 Jul; 41(1-2):173-81. PubMed ID: 7801520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens.
    Pitcovski J; Di-Castro D; Shaaltiel Y; Azriel A; Gutter B; Yarkoni E; Michael A; Krispel S; Levi BZ
    Avian Dis; 1996; 40(4):753-61. PubMed ID: 8980802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens.
    Vakharia VN; Snyder DB; He J; Edwards GH; Savage PK; Mengel-Whereat SA
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1201-6. PubMed ID: 8389805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2.
    Butter C; Sturman TD; Baaten BJ; Davison TF
    Avian Pathol; 2003 Dec; 32(6):597-604. PubMed ID: 14676010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.
    Taghavian O; Spiegel H; Hauck R; Hafez HM; Fischer R; Schillberg S
    PLoS One; 2013; 8(12):e83210. PubMed ID: 24376665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.
    Rogel A; Benvenisti L; Sela I; Edelbaum O; Tanne E; Shachar Y; Zanberg Y; Gontmakher T; Khayat E; Stram Y
    Virus Genes; 2003 Oct; 27(2):169-75. PubMed ID: 14501195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
    Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
    Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus.
    Omar AR; Kim CL; Bejo MH; Ideris A
    J Vet Sci; 2006 Sep; 7(3):241-7. PubMed ID: 16871018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune dysfunction following infection with chicken anemia agent and infectious bursal disease virus. II. Alterations of in vitro lymphoproliferation and in vivo immune responses.
    Cloud SS; Rosenberger JK; Lillehoj HS
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):353-66. PubMed ID: 1333677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptide motif of the single dominantly expressed class I molecule of the chicken MHC can explain the response to a molecular defined vaccine of infectious bursal disease virus (IBDV).
    Butter C; Staines K; van Hateren A; Davison TF; Kaufman J
    Immunogenetics; 2013 Aug; 65(8):609-18. PubMed ID: 23644721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious bursal disease subunit vaccination.
    Villegas P; Hamoud M; Purvis LB; Perozo F
    Avian Dis; 2008 Dec; 52(4):670-4. PubMed ID: 19166061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
    Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
    Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.